학술논문
Comparison of Teriparatide and Denosumab in Patients Switching From Long-Term Bisphosphonate Use.
Document Type
Article
Author
Source
The Journal of Clinical Endocrinology & Metabolism; November 2019, Vol. 104 Issue: 11 p5611-5620, 10p
Subject
Language
ISSN
0021972X; 19457197
Abstract
Teriparatide and denosumab are effective treatments for osteoporosis and typically reserved as second-line options after patients have used bisphosphonates. However, limited head-to-head comparative effectiveness data exist between teriparatide and denosumab.